Overdiagnosis of Thyroid Cancer Persists
By Lori Solomon HealthDay Reporter
WEDNESDAY, Feb. 12, 2025 -- Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb. 5 in The Lancet Diabetes & Endocrinology.
Michelle M. Chen, M.D., from Stanford University in Palo Alto, California, and colleagues examined whether U.S. thyroid cancer incidence has truly decreased or merely plateaued and to understand some of the underlying factors driving these trends. The analysis included 91,968 patients with thyroid cancer identified from the National Cancer Institute Surveillance, Epidemiology, and End Results database and the National Center for Health Statistics database (1975 to 2019).
The researchers found that the rise and subsequent plateau in the incidence of thyroid cancer have been primarily driven by time period effects, likely due to changing patterns in diagnostic pressure. The incidence of thyroid cancer by age increased during the study period and was driven predominantly by overdiagnosis. Although the incidence of thyroid cancer has plateaued, it remains at peak levels, suggesting that overdiagnosis remains a crucial unresolved public health issue.
"Further work is needed to help limit the current drivers of overdiagnosis and to implement novel solutions aimed at ... physicians, patients, and policy makers," the authors write.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition
WEDNESDAY, Feb. 12, 2025 -- Post-COVID condition (PCC) continues to affect children, and 80 percent of those currently experiencing PCC have activity limitation, according to a...
Performance of AI Preeclampsia Prediction Models Deteriorates Over Time
WEDNESDAY, Feb. 12, 2025 -- For the Preeclampsia Integrated Estimate of RiSk (PIERS) Machine Learning (PIERS-ML) model and the logistic regression-based fullPIERS model...
Use of Secondary CVD Prevention Medications Low in Most Countries
WEDNESDAY, Feb. 12, 2025 -- Use of secondary cardiovascular disease (CVD) prevention medications has improved little over time, according to a study published in the Feb. 11 issue...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.